Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-market Observational ORIGIN® vs. VANGUARD® PS Clinical Study: a Comparative, Prospective, Randomized Controlled Clinical and Radiological Evaluation.

NCT04728542 is registered in ClinicalTrials.gov with Symbios Orthopedie SA as lead sponsor.

NCT NCT04728542
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04728542 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-market Observational ORIGIN® vs. VANGUARD® PS Clinical Study: a Comparative, Prospective, Randomized Controlled Clinical and Radiological Evaluation.
Lead sponsor
Symbios Orthopedie SA
Phase
Observational
Overall status
Recruiting
Start date
March 25, 2021
Completion date
February 28, 2027
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arthroplasty, knee, replacement